Consigue una respuesta de este empleador
Tu currículum y tu carta de presentación, adaptados exactamente a lo que buscan contratar.
The Executive Director of Cancer Vaccine Neoantigen Engineering at AstraZeneca plc will lead the molecular engineering and construction of a portfolio of cancer vaccines designed to generate broad, potent, and durable anti-tumor cellular immunity.
You will integrate diverse data (genomic, immunopeptidomic, structural, TCR) to establish predictive design principles, optimize antigen designs, and build scalable, AI‑guided workflows across immunology, oncology, and translational science.
The Executive Director of Cancer Vaccine Neoantigen Engineering will lead the molecular engineering and construction of a portfolio of cancer vaccines designed to generate broad, potent, and durable anti‑tumor cellular immunity. The role will identify, prioritize, and engineer diverse tumor antigen classes and translate them into precision multi‑antigen/epitope constructs optimized for T‑cell breadth, clonal expansion, functional potency, and long‑term immune surveillance.
The Executive Director will build deep capabilities to master the rules governing antigen processing, pMHC presentation, and TCR recognition, integrating genomic, transcriptomic, immunopeptidomic, structural, and TCR repertoire data to understand what makes an antigen naturally presented, immunologically visible, and capable of driving functional tumor‑cell killing. These insights will establish predictive design principles for epitope selection and immunogen engineering. A major focus will be developing innovative antigen‑cassette architectures that robustly induce cellular immunity. Designs will seek to balance immunodominance, coordinate CD8⁺ cytotoxicity with CD4⁺ T‑cell help, minimize antigen escape, and maximize the magnitude, breadth, polyfunctionality, cytotoxicity and persistence of vaccine‑induced T‑cell responses.
The Executive Director will establish an integrated antigen‑engineering engine connecting computational design with experimental validation and iterative optimization. Working across immunology, oncology, computational sciences, protein engineering, and translational sciences, the role will build differentiated capabilities and intellectual property in engineered immunogens, multi‑antigen cassette architectures, immune‑routing strategies, and sequence‑design algorithms, creating a scalable platform for the predictive design of best‑in‑class cancer vaccines.
Annual base salary for this position ranges from $ 281,872.80 - $422,809.20. AstraZeneca is committed to providing fair and equitable compensation opportunities to all colleagues. Our compensation policies and practices have been designed to allow colleagues to progress through the salary range over time as they progress in their role. The range provided in this posting represents an offer pay range used in a majority of situations. The base pay offered will vary depending on multiple individualized factors, including the candidate's skills and experience, job‑related knowledge, and other specific business and organizational needs. In some cases, offers outside the range may also be considered to address unique circumstances.
In addition, our permanent positions offer an annual Variable Pay Bonus/Short Term Incentive opportunity as well as eligibility to participate in our equity‑based long‑term incentive program (if applicable to role). Benefits offered for permane